Serum-free media promotes more consistent cell growth and aids in the elimination of potential errors by reducing the proportion of unequal growth among cell cultures.

BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled Serum-Free Media Market -

A Global and Regional Analysis. According to this study, the market size of the global serum-free media market was valued at $1.02 billion in 2021 and is projected to reach $3.92 billion by 2032. The following factors are responsible for the increase in demand for serum-free media:

• Low risk of contamination as a demand driver
• Launch of innovative products in a serum-free media ecosystem
• Low reception cost involving small and medium enterprises in comparison to animal-derived media

The detailed study is a compilation of 10 market data tables and 114 figures spread through 165 pages.

Check out the detailed table of content here: https://bisresearch.com/requestsample?id=1361&type=toc

Analyst's Take on the Market Projection

According to Nitish Kumar, Principal Analyst, BIS Research, "Global serum-free media market has evolved to be an integrative aspect of healthcare procedures by providing most diagnostic laboratory tests equipped with infectious disease, oncology, and genetics. The massively parallel methods that have now transcended media-based cellular diagnostics further allow the sequencing of entire genomes at very low costs and are expected to grow further in the coming years due to the continuous increase in prognostic assessments for a wide range of diseases."

Request a FREE sample of this report here: https://bisresearch.com/requestsample?id=1361&type=download

Existing Competitive Landscape The companies that are profiled have been selected based on primary research inputs gathered from a network of industry experts and analyzing company coverage, product portfolio, and market penetration. Some of the prominent established names in this market are:

Company Type 1: Serum-Free Media Private Industry

• MP BIOMEDICALS.
• HiMedia Laboratories
• R&D Systems, Inc.
• Sino Biological, Inc.
• PAN-Biotech.
• PromoCell GmbH
• Athena Environmental Sciences, Inc.
• STEMCELL Technologies Inc.

Company Type 2: Serum-Free Media Public Industry

• Corning Incorporated
• Lonza Group AG
• Merck KgaA
• Sartorius AG
• Thermo Fisher Scientific Inc.
• FUJIFILM Holdings Corporation
• Danaher

Recent Developments in the Global Serum-Free Media Market

• In August 2022, Thermo Fisher Scientific Inc. expanded the cell culture media manufacturing facility in Grand Island, New York, to support the production of new vaccines and biologics.
• In May 2022, FUJIFILM Irvine Scientific completed its new bioprocessing innovation and collaboration center in China.
• In September 2021, Bio-Techne Corporation developed a new medium ExCellerate IpsC expansion medium, for IpsC research in regenerative medicine.

Biopharmaceutical Companies Projected to Lead the End User Segment

Cell culture is an essential component of biotechnology and is employed in a wide range of commercial and academic applications. Cell culture research is used in a variety of fields, including genetics, cell therapy, and regenerative medicine. According to the study conducted by BIS Research, the global serum-free media market (by end-user) was dominated by biopharmaceutical companies in 2021. This trend is expected to continue during the forecast period 2022-2032, with the segment anticipated to grow at a CAGR of 13.44%. Increasing global serum-free media research activities are expected to contribute to the growth of the market along with growing industry-academic collaborations for new product development.

Want to learn more about healthcare market trends? Speak to our analysts

Exclusive DeepTechTM MAP Analysis For Healthcare Industry by BIS Research: Global Recombinant Cell Culture Supplements Market

About BIS Research:

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends which can disrupt the market dynamics in the near future. We publish more than 200 market intelligence studies annually that focus on several deep technology verticals. Our strategic market analysis emphasizes on market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management. BIS Research offers syndicate as well as custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscape.

Contact:

Bhavya Banga

Email: [email protected]

BIS Research Inc. 39111

PASEO PADRE PKWY STE 313,FREMONT CA 94538-1686

Visit our Blog @ https://bisresearch.com/news

Get Expert Insights @ https://community.insightmonk.com

Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research

Connect with us on Twitter@ https://twitter.com/BISResearch

Tags: Healthcare, Market Research, Biopharma, DeepTech

See Campaign: https://bit.ly/3ChYtPo

Contact Information:

[email protected]